Australian Clinical Labs Ltd (AU:ACL) has released an update.
Australian Clinical Labs Ltd, a major private pathology service provider in Australia, has announced its 2024 Annual General Meeting. The company released essential documents for shareholders, including the Annual Report and Corporate Governance Statement, with details available on pages 50 to 64 of the report. The governance statement, up to date as of 26 August 2024, has received Board approval.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.